Log in
Enquire now
‌

US Patent 11014965 Modulation of complement activity

Patent 11014965 was granted and assigned to Ra Pharmaceuticals on May, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Ra Pharmaceuticals
Ra Pharmaceuticals
Current Assignee
Ra Pharmaceuticals
Ra Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11014965
Date of Patent
May 25, 2021
Patent Application Number
16732502
Date Filed
January 2, 2020
Patent Citations
‌
US Patent 10435438 Modulation of complement activity
‌
US Patent 10106579 Modulation of complement activity
‌
US Patent 10208089 Modulation of complement activity
‌
US Patent 10328115 Modulators of complement activity
‌
US Patent 10588936 Modulators of complement activity
Patent Primary Examiner
‌
Jeanette M Lieb
Patent abstract

The present invention provides modulators of complement activity. Also provided are methods of utilizing such modulators as therapeutics.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11014965 Modulation of complement activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.